Large trial shows efficacy and lower incidences of heart issues and bleeding events with novel non-covalent BTK inhibitor
Regular surveillance necessary to identify safety signals
Autologous anti-CD19 agent produces impressive survival improvements
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy